SNORA71B

Across TCGA pan-cancer cohorts, SNORA71B RNA is linked to patient survival in 23 of 34 cancer types, making it the most broadly survival-associated SNORA71B data layer.

The strongest signal is observed in kidney renal clear cell carcinoma (KIRC), where higher SNORA71B RNA is associated with worse disease-free survival. In most high-consensus cancer types, elevated SNORA71B expression acts as an unfavorable survival marker, although some lineages such as READ and HNSC show a favorable association.

KIRC, READ, and HNSC are the cancer types where SNORA71B RNA most reproducibly stratifies survival.

RNA survival associations by lineage

Ranked by sampling consensus. AUC1 and AUC2 indicate survival in the high- and low-expression groups, respectively; the lower AUC marks the poorer-surviving group. p-values are from the log-rank test.

Lineage	Measure	Split	Stage	AUC1 high	AUC2 low	p	Sampling consensus
KIRC	DFS	Quartile	III,IV	0.274	0.663	.003	66	view →
READ	OS	Tertile	All	0.782	0.323	.001	45	view →
HNSC	DFS	Quartile	IV	0.609	0.425	.012	44	view →
LUAD	OS	Quartile	II,III,IV	0.829	0.542	.001	42	view →
UCEC	OS	Tertile	All	0.903	0.968	.001	40	view →
LGG	DFS	Median	All	0.772	0.890	<.001	36	view →
KICH	DFS	Tertile	III,IV	0.256	0.931	.001	33	view →
THCA	OS	Quartile	II,III,IV	0.646	1.000	.002	23	view →
BRCA	OS	Quartile	III,IV	0.951	0.857	.011	22	view →
CESC	DFS	Median	All	0.780	0.863	.013	18	view →
UVM	DFS	Quartile	III,IV	0.224	0.672	.011	14	view →
DLBC	DFS	Median	All	0.629	1.000	.017	11	view →

Pink = unfavorable, green = favorable. Showing the 12 strongest of 23 lineages.

SNORA71B–KIRC (DFS)

Open the KIRC breakdown →